Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.

Also called NCT04696523

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04696523
  • EudraCT 2019-001542-17
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Finland, Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04696523. Randomized; double masking; primary purpose treatment. Start 2025-04-22 (actual); primary completion 2029-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
Acronym
Xe-SAH
Condition
Subarachnoid Hemorrhage, Aneurysmal
Condition
Cerebral Injury
Condition
Cerebral Ischemia
Condition
Cerebral Infarction
Condition
Cardiac Event
Condition
Cardiac Failure
Intervention (Drug)
Xenon
Intervention (Drug)
air/oxygen
Lead sponsor
Turku University Hospital (class: other government)
Collaborator
Academy of Finland (class: other)

Record details

Record id
cardio:ct-nct04696523
Content hash
334a76f1345c447620cb2de78cfc81d82cfee5ae1665b1fac1d2028b9ecc0963